Home » Topics » Regulatory

Regulatory
RSS

Apomorphine designated orphan drug

Nov. 7, 1997

Gensia Sicor terminates collaboration with Atrix

Nov. 7, 1997

Patient enrollment complete for phase II trial of memantine

Nov. 6, 1997

FDA approves generic formulation of oxycodone/acetaminophen

Nov. 6, 1997

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Nov. 3, 1997

Clinical data reported for Actiq

Nov. 3, 1997

FDA clears generic cimetidine

Oct. 29, 1997

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

FDA clears generic estradiol product

Oct. 29, 1997

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...